Key result
Patients with established CHD in Baghdad exhibited high rates of elevated total cholesterol (67%), D-dimer (53%), CRP (47%), and troponin (27%), with mean systolic blood pressure of 146.8 mmHg.
Why the study?
Coronary heart disease remains a major cause of cardiovascular morbidity and mortality, motivating the characterisation of clinical and biochemical profiles of adults with established CHD receiving specialist care in Baghdad, Iraq.
Cross-Sectional (n=100)
No
This descriptive cross-sectional study documents a high prevalence of traditional cardiovascular risk factors and elevated lipid, glycemic, inflammatory, thrombotic, and myocardial injury biomarkers among patients receiving specialist care for established CHD in Baghdad, Iraq, despite frequent use of preventive medications.
Answers are grounded in this paper and cite their sources.
High residual risk factor and biomarker burden persists in treated Baghdad CHD patients; leaves open optimal region-specific strategies for Global South cohorts.
Introduction: Coronary heart disease (CHD) remains a major cause of cardiovascular morbidity and mortality. This study described selected clinical and biochemical characteristics of adults with established CHD receiving specialist care in Baghdad, Iraq. Methods: A descriptive cross-sectional study included 100 adults with cardiologist-confirmed CHD who attended Ibn Al-Baytar Centre for Heart Surgery between February and June 2025. Sociodemographic and clinical information was obtained from a structured questionnaire and medical records. Total cholesterol, triglycerides, blood glucose, C-reactive protein (CRP), D-dimer, cardiac troponin and blood pressure were summarised descriptively, including sex-stratified categorical distributions. Results: Fifty participants were male and 50 female; 80% were aged 50–100 years. Family history of cardiovascular disease, hypertension, diabetes mellitus and obesity were reported in 63%, 57%, 47% and 27%, respectively. Lipid-lowering, antihypertensive and antidiabetic treatments were documented in 70%, 53% and 47%. Mean total cholesterol was 232.4 ± 41.6 mg/dL, triglycerides 198.7 ± 52.3 mg/dL, glucose 176.2 ± 48.9 mg/dL, CRP 8.6 ± 3.4 mg/L, D-dimer 612.5 ± 210.7 ng/mL, troponin 0.041 ± 0.018 ng/mL and systolic blood pressure 146.8 ± 18.5 mmHg. Conclusion: The study describes a substantial burden of cardiovascular risk factors and abnormal biomarker measurements among patients with established CHD. Because there was no independent comparison group and no measure of disease severity or follow-up outcome, the findings do not establish diagnostic performance, causality or incremental prognostic value.
No takes yet. Share an insight, caveat, or question.
Sura Samir Mohammed (2026) conducted a cross-sectional in Established coronary heart disease (CHD) (n=100). Established coronary heart disease was evaluated on Descriptive clinical and biochemical biomarker distributions (total cholesterol, triglycerides, blood glucose, CRP, D-dimer, cardiac troponin, and systolic blood pressure). Patients with established CHD in Baghdad exhibited high rates of elevated total cholesterol (67%), D-dimer (53%), CRP (47%), and troponin (27%), with mean systolic blood pressure of 146.8 mmHg.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: